|
1
|
Centers for Disease Control and
Prevention: What is Colorectal Cancer? Centers for Disease Control
and Prevention. Available from: https://www.cdc.gov/cancer/colorectal/basic_info/what-is-colorectal-cancer.htm.
Accepted at March 19, 2022.
|
|
2
|
American Society of Clinical Oncology.
Colorectal Cancer-Types of Treatment. Cancer.Net. Available
from: https://www.cancer.net/cancer-types/colorectal-cancer/types-treatment.
Accepted at March 19, 2022.
|
|
3
|
Brasky TM, Liu J, White E, Peters U,
Potter JD, Walter RB, Baik CS, Lane DS, Manson JAE, Vitolins MZ, et
al: Non-steroidal anti-inflammatory drugs and cancer risk in women:
Results from the women's health initiative. Int J Cancer.
135:1869–1883. 2014.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Kodela R, Nath N, Chattopadhyay M, Nesbitt
DE, Velázquez-Martínez CA and Kashfi K: Hydrogen sulfide-releasing
naproxen suppresses colon cancer cell growth and inhibits NF-κB
signaling. Drug Des Devel Ther. 9:4873–4882. 2015.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Mohammed A, Janakiram NB, Madka V, Zhang
Y, Singh A, Biddick L, Li Q, Lightfoot S, Steele VE, Lubet RA, et
al: Intermittent dosing regimens of aspirin and naproxen inhibit
azoxymethane-induced colon adenoma progression to adenocarcinoma
and invasive carcinoma. Cancer Prev Res (Phila). 12:751–762.
2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Reyes-Uribe L, Wu W, Gelincik O, Bommi PV,
Francisco-Cruz A, Solis LM, Lynch PM, Lim R, Stoffel EM, Kanth P,
et al: Naproxen chemoprevention promotes immune activation in Lynch
syndrome colorectal mucosa. Gut. 70:555–566. 2021.PubMed/NCBI View Article : Google Scholar
|
|
7
|
CasPASE™ Apoptosis Assay-G-Biosciences.
G-Biosciences. Available from: https://cdn.gbiosciences.com/pdfs/protocol/Caspase_Apoptosis_Colorimentric_Assay_BAQ.pdf.
Accepted March 12, 2022.
|
|
8
|
Bumgarner R: Overview of DNA microarrays:
Types, applications, and their future. Curr Protoc Mol Biol Chapter
22:Unit 22.1, 2013.
|
|
9
|
Rao MS, Van Vleet TR, Ciurlionis R, Buck
WR, Mittelstadt SW, Blomme EAG and Liguori MJ: Comparison of
RNA-seq and microarray gene expression platforms for the
toxicogenomic evaluation of liver from short-term RAT toxicity
studies. Front Genet. 9(636)2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Elabscience. Human muc5ac(mucin 5 subtype
AC) Elisa Kit. Elabscience. Available from: https://www.elabscience.com/p-human_muc5ac_mucin_5_subtype_ac_elisa_kit-19687.html.
Accepted May 6, 2023.
|
|
11
|
Smith CE, Soti S, Jones TA, Nakagawa A,
Xue D and Yin H: Non-steroidal anti-inflammatory drugs are caspase
inhibitors. Cell Chem Biol. 24:281–292. 2017.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Crowley LC and Waterhouse NJ: Detecting
cleaved caspase-3 in apoptotic cells by flow cytometry. Cold Spring
Harb Protoc 2016: 2016.
|
|
13
|
Lahdaoui F, Messager M, Vincent A, Hec F,
Gandon A, Warlaumont M, Renaud F, Leteurtre E, Piessen G,
Jonckheere N, et al: Depletion of MUC5B mucin in gastrointestinal
cancer cells alters their tumorigenic properties: Implication of
the Wnt/β-catenin pathway. Biochem J. 474:3733–3746.
2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Wang Y, Yin K, Tian J, Xia X, Ma J, Tang
X, Xu H and Wang S: Granulocytic myeloid-derived suppressor cells
promote the stemness of colorectal cancer cells through exosomal
S100A9. Adv Sci (Weinh). 6(1901278)2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Pothuraju R, Rachagani S, Krishn SR,
Chaudhary S, Nimmakayala RK, Siddiqui JA, Ganguly K, Lakshmanan I,
Cox JL, Mallya K, et al: Molecular implications of MUC5AC-CD44 axis
in colorectal cancer progression and chemoresistance. Mol Cancer.
19(37)2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Yuan S, Liu Q, Hu Z, Zhou Z, Wang G, Li C,
Xie W, Meng G, Xiang Y, Wu N, et al: Long non-coding RNA MUC5B-AS1
promotes metastasis through mutually regulating MUC5B expression in
lung adenocarcinoma. Cell Death Dis. 9(450)2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Choi YS, Na HG, Bae CH, Song S and Kim Y:
Pepsin exposure in a non-acidic environment upregulates mucin 5AC
(MUC5AC) expression via matrix metalloproteinase 9 (mmp9)/nuclear
factor ΚB (NF-ΚB) in human airway epithelial cells. Int Forum
Allergy Rhinol. 11:894–901. 2021.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Song EJ, Bae CH, Kim JY, Kim YW, Park SY,
Song SY and Kim YD: Effect of epigallocatechin-3-gallate on
PMA-induced MUC5B expression in human airway epithelial cells. Clin
Exp Otorhinolaryngol. 6:237–242. 2013.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Shi S and Yi JL: S100A8/A9 promotes MMP-9
expression in the fibroblasts from cardiac rupture after myocardial
infarction by inducing macrophages secreting TNFα. Eur Rev Med
Pharmacol Sci. 22:3925–3935. 2018.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Murray D, Morrin M and McDonnell S:
Increased invasion and expression of MMP-9 in human colorectal cell
lines by a CD44-dependent mechanism. Anticancer Res. 24:489–494.
2004.PubMed/NCBI
|
|
21
|
Espinosa-Cano E, Huerta-Madroñal M,
Cámara-Sánchez P, Seras-Franzoso J, Schwartz S Jr, Abasolo I, San
Román J and Aguilar MR: Hyaluronic acid (ha)-coated
naproxen-nanoparticles selectively target breast cancer stem cells
through COX-independent pathways. Mater Sci Eng C Mater Biol Appl.
124(112024)2021.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Kim MS, Kim JE, Lim DY, Huang Z, Chen H,
Langfald A, Lubet RA, Grubbs CJ, Dong Z and Bode AM: Naproxen
induces cell-cycle arrest and apoptosis in human urinary bladder
cancer cell lines and chemically induced cancers by targeting PI3K.
Cancer Prev Res (Phila). 7:236–245. 2014.PubMed/NCBI View Article : Google Scholar
|
